Clinical Trial Update: Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of Hemay005, intended for psoriasis, in healthy male subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Hemay005

Snippet

Sponsor: Tianjin Hemay Bio-Tech Co., Ltd | Conditions: Psoriasis | Phase 1 | Status: COMPLETED